Does an elevated N‑terminal pro B‑type natriuretic peptide (NT‑proBNP) indicate acute decompensated heart failure rather than myocardial injury after non‑cardiac surgery (MINS)?

Elevated NT-proBNP Does NOT Reliably Distinguish Acute Decompensated Heart Failure from MINS

An elevated NT-proBNP alone cannot definitively point to acute decompensated heart failure rather than MINS—both conditions cause NT-proBNP elevation, and the 2024 AHA/ACC guidelines explicitly list acute decompensated heart failure as a nonischemic cause of myocardial injury that must be excluded when diagnosing MINS. 1

The Clinical Reality: NT-proBNP Elevates in Both Conditions

The fundamental issue is that NT-proBNP reflects myocardial stress from multiple etiologies:

• MINS causes NT-proBNP elevation: Preoperative NT-proBNP >100 pg/mL identifies patients at 3.5-fold increased risk of postoperative myocardial injury 2, and elevated levels independently predict MINS in vascular surgery patients 3

• Acute decompensated heart failure causes NT-proBNP elevation: This is well-established, with NT-proBNP being a cornerstone biomarker for heart failure diagnosis and risk stratification 4, 5

• The overlap is substantial: In one perioperative cohort, 41.9% of patients had NT-proBNP >100 pg/mL preoperatively, yet only 8.9% had a formal diagnosis of heart failure 2

How to Actually Differentiate: The Algorithmic Approach

The 2024 AHA/ACC guidelines provide the framework 1:

Step 1: Confirm Acute Myocardial Injury

• Elevated troponin (>99th percentile) with rise and/or fall pattern
• Serial measurements essential to distinguish acute from chronic elevation

Step 2: Look for Ischemic Features

If present, this is MINS with ischemic features:

• Ischemic ECG changes (ST-segment changes, new Q waves)
• Ischemic symptoms (though often absent due to anesthesia/analgesia)
• Imaging evidence of new loss of viable myocardium

If absent, proceed to Step 3

Step 3: Exclude Nonischemic Causes of Myocardial Injury

The guidelines explicitly list these as alternative diagnoses to MINS:

• Acute decompensated heart failure
• Pulmonary embolism
• Sepsis
• Acute stroke

Step 4: Clinical Assessment for Heart Failure

Look for these specific findings to diagnose acute decompensated heart failure:

• Pulmonary edema on exam or imaging
• Elevated jugular venous pressure
• New or worsening dyspnea at rest
• Rales on lung examination
• Peripheral edema (though less specific perioperatively)
• Requirement for diuretics or escalation of heart failure therapy
• Echocardiographic evidence of reduced ejection fraction or diastolic dysfunction with volume overload

The Magnitude of NT-proBNP Matters, But Doesn't Solve the Problem

Higher NT-proBNP levels increase the likelihood of both conditions:

• NT-proBNP ≥1500 pg/mL: Associated with 37.5% incidence of vascular death/MINS within 30 days 6, but also predicts 4.0% 30-day mortality in acute heart failure 7

• NT-proBNP >450 pg/mL: Independently predicts postoperative acute decompensated heart failure (20.1% incidence) 8

The absolute level helps with risk stratification but not differential diagnosis.

Common Pitfalls to Avoid

1. Don't assume elevated NT-proBNP = heart failure: Many patients with elevated NT-proBNP and postoperative troponin elevation have MINS from coronary ischemia, not heart failure 2, 3

2. Don't ignore troponin patterns: The rise-and-fall pattern distinguishes acute injury from chronic elevation—this is critical for both diagnoses 1

3. Don't forget that MINS is often asymptomatic: 80-90% of MINS cases lack ischemic symptoms, making clinical differentiation even more challenging 1

4. Don't overlook that both can coexist: Type 2 MI (supply-demand mismatch) can occur in the setting of acute decompensated heart failure

The Bottom Line for Clinical Decision-Making

When you see elevated troponin + elevated NT-proBNP postoperatively:

1. First, determine if there are clear clinical signs of volume overload and heart failure (pulmonary edema, elevated JVP, need for diuretics)

   • If YES → Treat as acute decompensated heart failure
   • If NO → Proceed to next step

2. Second, look for ischemic features (ECG changes, symptoms, imaging)

   • If YES → MINS with ischemic features (higher mortality risk)
   • If NO → MINS without ischemic features (still significant mortality risk)

3. Third, consider cardiology consultation regardless of the diagnosis, as this improves 30-day mortality 1

4. Fourth, initiate appropriate therapy:

   • For MINS: Consider aspirin, statin, and potentially anticoagulation (dabigatran showed benefit in the MANAGE trial) 1
   • For acute decompensated heart failure: Diuretics and guideline-directed heart failure therapy

The NT-proBNP level itself does not make the distinction—clinical context, physical examination findings, and imaging are required to differentiate these overlapping conditions.